Markets:

Overview

News

Currencies

International

Treasuries

Biohaven Ltd. Common Shares (NY:BHVN)

12.99 -0.52 (-3.88%)

Streaming Delayed Price Updated: 11:19 AM EST, Jan 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biohaven Ltd. Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

June 10, 2025

From Bexorg

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

June 10, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

June 06, 2025

From Pomerantz LLP

Via GlobeNewswire

Why Biohaven Stock Triumphed on Tuesday ↗

February 11, 2025

Via The Motley Fool

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

June 02, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

May 28, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

May 22, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

May 18, 2025

From Pomerantz LLP

Via GlobeNewswire

Why Biohaven Stock Dove by Nearly 20% on Thursday ↗

May 15, 2025

Via The Motley Fool

Why Is Biohaven Stock Falling On Thursday? ↗

May 15, 2025

Biohaven secures $250 million from Oberland Capital, with total cash reaching $518 million to support troriluzole launch and operations.

Via Benzinga

Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug ↗

May 15, 2025

The company hadn't expected an advisory committee meeting, nor a three-month pushback for its rare-disease drug review.

Via Investor's Business Daily

Red Cat Holdings, Alibaba, DXC Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

May 15, 2025

Via Benzinga

Why BioHaven Stock Is Soaring Today ↗

April 28, 2025

Via The Motley Fool

Topics Stocks

Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland ↗

April 28, 2025

Biohaven Ltd. (BHVN) shares rise premarket as it secures up to $600 million investment from Oberland Capital. Cash reserves expected to reach $489 million.

Via Benzinga

Stride To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday ↗

April 28, 2025

Via Benzinga

Why Biohaven Stock Plummeted by More Than 15% Today ↗

April 25, 2025

Via The Motley Fool

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

April 21, 2025

From Pomerantz LLP

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

April 18, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

April 17, 2025

From Pomerantz LLP

Via GlobeNewswire

BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm

April 13, 2025

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

April 12, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

April 07, 2025

From Pomerantz LLP

Via GlobeNewswire

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March ↗

April 03, 2025

Via The Motley Fool

Topics Bankruptcy Economy World Trade

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN

April 03, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN

March 30, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN

March 26, 2025

From Pomerantz LLP

Via GlobeNewswire

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

March 26, 2025

From Avalo Therapeutics

Via GlobeNewswire

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity ↗

March 04, 2025

Analysts remains bullish on the company's chances in depression and epilepsy. But investors aren't convinced.

Via Investor's Business Daily

Strong Immunoglobulin Reduction Data Positions Biohaven's BHV-1300 As Potential Autoimmune Therapy ↗

March 03, 2025

Biohaven's BHV-1300 reduced IgG levels by up to 84% in a Phase 1 trial for autoimmune disease, with rapid and sustained effects and a favorable safety profile.

Via Benzinga

Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday? ↗

March 03, 2025

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%,...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.